Rebello, Richard J. http://orcid.org/0000-0001-6271-6678
Oing, Christoph http://orcid.org/0000-0001-5578-3418
Knudsen, Karen E.
Loeb, Stacy
Johnson, David C.
Reiter, Robert E.
Gillessen, Silke
Van der Kwast, Theodorus
Bristow, Robert G. http://orcid.org/0000-0002-8553-9544
Article History
Accepted: 23 December 2020
First Online: 4 February 2021
Competing interests
: R.J.R.: No competing interests. C.O.: Travel reimbursement from Ipsen, PharmaMar and Medac; research funding from Roche and PharmaMar. Speakers honoraria from Ipsen, Roche and Medac. K.E.K.: Consultant/advisor to Cell Centric, Sanofi, Celgene, Atrin and Genentech. S.L.: Reimbursed travel to the Prostate Cancer Foundation Retreat from Sanofi; consulting fees from Lumenis and Bayer; equity in Gilead. D.C.J.: No competing interests. R.E.R.: Speakers bureau for Janssen and Genomic Health; consultant/advisor to Progenics, Pfizer, Janssen, Exact Biosciences and Bayer. S.G.: Consultant/advisor to Janssen, Astellas Pharma (Inst.), Curevac (Inst.), Novartis (Inst.), Active Biotech (Inst.), Bristol-Myers Squibb (Inst.), Ferring (Inst.), MaxiVax, Advanced Accelerator Applications, Roche, Janssen (Inst.), Innocrin Pharma (Inst.), Sanofi, Bayer (Inst.), Orion Pharma GmbH, Clovis Oncology (Inst.) and Menarini Silicon Biosystems (Inst.); patents, royalties or other intellectual property in Method for biomarker (WO 3752009138392 A1); other relationships with Nektar and ProteoMediX. T.V.d.K.: Consultant/advisor to Janssen. R.G.B.: Advisory board to AstraZeneca and Astellas; grant from GenomeDX.